↓ Skip to main content

Dove Medical Press

Article Metrics

Clinical utility of targeted treatments in the management of epithelial ovarian cancer

Overview of attention for article published in Biologics: Targets & Therapy, July 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
6 Mendeley
Title
Clinical utility of targeted treatments in the management of epithelial ovarian cancer
Published in
Biologics: Targets & Therapy, July 2012
DOI 10.2147/btt.s29356
Pubmed ID
Authors

Ernest Han, Cheryl Twu

Abstract

Epithelial ovarian cancer is typically found in its advanced stages, where a combination of surgical debulking and platinum/taxane-based chemotherapy is recommended. Although over 70%-80% of patients achieve remission, a significant proportion develop recurrence of their disease. Additional cytotoxic chemotherapy, as well as surgery, is typically used to manage disease recurrence. Therapies that target specific pathways in cancer cells are rapidly developing in the laboratory and are increasingly being studied in patients with ovarian cancer. We review the current status of novel therapies in the management of epithelial ovarian cancer.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 33%
Professor 1 17%
Student > Doctoral Student 1 17%
Other 1 17%
Student > Master 1 17%
Other 0 0%
Readers by discipline Count As %
Physics and Astronomy 2 33%
Psychology 1 17%
Economics, Econometrics and Finance 1 17%
Agricultural and Biological Sciences 1 17%
Chemistry 1 17%
Other 0 0%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2012.
All research outputs
#10,606,409
of 16,569,218 outputs
Outputs from Biologics: Targets & Therapy
#133
of 219 outputs
Outputs of similar age
#76,529
of 130,382 outputs
Outputs of similar age from Biologics: Targets & Therapy
#9
of 12 outputs
Altmetric has tracked 16,569,218 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 219 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 130,382 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.